<DOC>
<DOCNO>EP-0655247</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Use of vincristine for the evaluation of substances at the neuroral level
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3144	A61K31475	G01N3350	A61K3144	G01N3350	A61K31475	A61K	C07D21100	A61K31451	C12Q100	A61B500	A61K4900	G01N3315	A61K31445	A61P2500	C07D21170	A61K31451	C12Q100	G01N3315	A61K4900	A61P2528	A61K31445	A61B500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	G01N	A61K	G01N	A61K	A61K	C07D	A61K	C12Q	A61B	A61K	G01N	A61K	A61P	C07D	A61K	C12Q	G01N	A61K	A61P	A61K	A61B	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	G01N33	A61K31	G01N33	A61K31	A61K	C07D211	A61K31	C12Q1	A61B5	A61K49	G01N33	A61K31	A61P25	C07D211	A61K31	C12Q1	G01N33	A61K49	A61P25	A61K31	A61B5	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to a method of evaluation of substances which are active at neuronal level, which consists in producing neuronal lesions in experimental animals by injecting an effective amount of vincristine into their medium septum, and in then evaluating the activity of the aforementioned substances in morphological and/or biochemical tests.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
SANOFI SYNTHELABO
</APPLICANT-NAME>
<APPLICANT-NAME>
SANOFI-SYNTHELABO
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
COUDE FRANCOIS-XAVIER
</INVENTOR-NAME>
<INVENTOR-NAME>
FOURNIER JACQUELINE
</INVENTOR-NAME>
<INVENTOR-NAME>
GUZZI UMBERTO
</INVENTOR-NAME>
<INVENTOR-NAME>
COUDE, FRANCOIS-XAVIER
</INVENTOR-NAME>
<INVENTOR-NAME>
FOURNIER, JACQUELINE
</INVENTOR-NAME>
<INVENTOR-NAME>
GUZZI, UMBERTO
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A method for the pharmacological screening of neuronally
active substances which comprises:


producing neuronal lesions to non-human animals intended
for pharmacological experimentation by injection in the medial

septum of the animals of an amount of vincristine effective to
this purpose;
administering the substance to be tested to the lesioned
animals according to the suitably selected schedule ;
sacrificing the animals ;

and
evaluating the effects of the treatment by means of
morphological and/or biochemical assays.
</CLAIMS>
</TEXT>
</DOC>
